Skip to main content

Tax receipts

Your 2020-2021 tax receipt will be sent mid-July. Contact us if you need to update your details.

Contact us

Through collaboration with the HRI’s Vascular Complications Group, we continue to study potential therapies to boost TRAIL, a novel mediator with marked anti-inflammatory and anti-atherosclerotic properties, in patients with coronary disease.

This work has resulted in several presentations at international cardiovascular meetings, and two publications.

EOFY tax receipts will be sent mid-July

Contact us